Simple Summary One of the important efforts in the treatment of cancers is to achieve
targeted drug delivery by nanocarriers to be more effective and reduce adverse effects …

Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high
recurrence and poor prognosis. The standard of care, surgical resection followed by …

Following its discovery more than 30 years ago, the enhanced permeability and retention
(EPR) effect has become the guiding principle for cancer nanomedicine development. Over …

Nano-zirconia, as an amphoteric semiconductor, has been industrially exploited in
photocatalytic reactions and as piezoelectric sensors. However, its biomedical applications …

The development of antiviral treatment and anticancer theragnostic agents in recent
decades has been associated with nanotechnologies, and primarily with inorganic …

Nanobio interaction studies have generated a significant amount of data. An important next
step is to organize the data and design computational techniques to analyze the nanobio …

The therapeutics based on nanoparticles (NPs) are considered as the promising strategy for
tumor detection and treatment. However, one of the most challenges is the adsorption of …

The bloodstream is the main transporting pathway for drug delivery systems (DDS) from the
site of administration to the intended site of action. In many cases, components of the …

In the last two decades, DNA has attracted significant attention toward the development of
materials at the nanoscale for emerging applications due to the unparalleled versatility and …

The innovative development of nanomedicine has promised effective treatment options
compared to the standard therapeutics for cancer therapy. However, the efficiency of EPR …